SE437930B - PROCEDURE FOR PREPARING A Permanent, BASED-PHARMACEUTICAL COMPOSITION - Google Patents

PROCEDURE FOR PREPARING A Permanent, BASED-PHARMACEUTICAL COMPOSITION

Info

Publication number
SE437930B
SE437930B SE7500501A SE7500501A SE437930B SE 437930 B SE437930 B SE 437930B SE 7500501 A SE7500501 A SE 7500501A SE 7500501 A SE7500501 A SE 7500501A SE 437930 B SE437930 B SE 437930B
Authority
SE
Sweden
Prior art keywords
permanent
preparing
procedure
pharmaceutical composition
pharmaceutical
Prior art date
Application number
SE7500501A
Other languages
Swedish (sv)
Other versions
SE7500501L (en
Inventor
C J Mcloughlin
R B Himstedt
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of SE7500501L publication Critical patent/SE7500501L/
Publication of SE437930B publication Critical patent/SE437930B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7500501A 1974-01-18 1975-01-17 PROCEDURE FOR PREPARING A Permanent, BASED-PHARMACEUTICAL COMPOSITION SE437930B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE7500501L SE7500501L (en) 1975-07-21
SE437930B true SE437930B (en) 1985-03-25

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500501A SE437930B (en) 1974-01-18 1975-01-17 PROCEDURE FOR PREPARING A Permanent, BASED-PHARMACEUTICAL COMPOSITION

Country Status (18)

Country Link
JP (1) JPS5837284B2 (en)
AT (1) AT349150B (en)
AU (1) AU485660B2 (en)
BE (1) BE824509A (en)
CA (1) CA1040532A (en)
CH (1) CH622947A5 (en)
DE (1) DE2501787A1 (en)
DK (1) DK151770C (en)
ES (1) ES433908A1 (en)
FI (1) FI750113A (en)
FR (1) FR2258177B1 (en)
GB (1) GB1478742A (en)
IE (1) IE40361B1 (en)
IT (1) IT1036072B (en)
LU (1) LU71668A1 (en)
NL (1) NL185130C (en)
SE (1) SE437930B (en)
ZA (1) ZA74385B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ATE318144T1 (en) * 1985-06-13 2006-03-15 Barry James Marshall PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL CONDITIONS, CONTAINING BISMUT AND AN ANTIMICROBIAL AGENT
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0363502B1 (en) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Liquid formulation containing bismuth, process to prepare it and use thereof
DE3901508C2 (en) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Drug based on a bismuth-containing preparation in solid form
IT1229502B (en) * 1989-01-25 1991-09-03 Euroresearch Srl COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
ES2084174T3 (en) * 1990-07-20 1996-05-01 Tillotts Pharma Ag PRODUCTS AND PROCESSES FOR THE TREATMENT OF THE FOOD DUCT.
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (en) 1997-05-28 1998-11-30 J Marshall M D Barry Procedure to prepare a reactive pharmaceutical product to detect gastrointestinal disorder caused by bacteria in superior gastrointestinal tract.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (en) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Improved bismuth preparations
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes

Also Published As

Publication number Publication date
GB1478742A (en) 1977-07-06
AU7729375A (en) 1976-07-15
DK151770C (en) 1989-11-06
SE7500501L (en) 1975-07-21
DK151770B (en) 1988-01-04
IT1036072B (en) 1979-10-30
IE40361B1 (en) 1979-05-09
FR2258177B1 (en) 1978-07-21
NL185130C (en) 1990-02-01
FR2258177A1 (en) 1975-08-18
CA1040532A (en) 1978-10-17
LU71668A1 (en) 1975-06-24
DE2501787A1 (en) 1975-07-24
DE2501787C2 (en) 1987-11-12
AU485660B2 (en) 1977-07-28
ZA74385B (en) 1975-08-27
CH622947A5 (en) 1981-05-15
JPS5837284B2 (en) 1983-08-15
NL185130B (en) 1989-09-01
NL7500552A (en) 1975-07-22
IE40361L (en) 1975-07-18
JPS50116623A (en) 1975-09-12
BE824509A (en) 1975-07-17
ATA31875A (en) 1978-08-15
AT349150B (en) 1979-03-26
DK12675A (en) 1975-09-15
ES433908A1 (en) 1976-11-16
FI750113A (en) 1975-07-19

Similar Documents

Publication Publication Date Title
SE437930B (en) PROCEDURE FOR PREPARING A Permanent, BASED-PHARMACEUTICAL COMPOSITION
SE423633B (en) PROCEDURE FOR PREPARING 4-DEMETOXY-DAUNOMYCINE
DK487475A (en) PROCEDURE FOR PREPARING WATER-EVENING POLYALKYLENOXIDE
SE421919B (en) PROCEDURE FOR PREPARING 2-TETRAHYDROFURFURYL-6,7-BENZOMORPHANES
SE7508406L (en) PROCEDURE FOR PREPARING POLYPHENYLENOXIDE.
IT1042173B (en) PROCEDURE FOR PREPARING BUTANDIOLI
SE431211B (en) PROCEDURE FOR PREPARING N-ACYLAMINO-ALFA-ARYLACETAMIDO-CEPHALOSPORINES
DK292475A (en) PROCEDURE FOR PREPARING 3-AMINO-2-HYDROXY-1-PHENOXY-PROPANE DERIVATIVES
DK146535C (en) METHOD FOR PREPARING 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE-3-CARBOXAMIDES
DK351875A (en) PROCEDURE FOR PREPARING 7-METHOXY-6-THIATETRACYLINES
SE7508074L (en) PROCEDURE FOR PREPARING STILBENDER DERIVATIVES.
SE7507324L (en) PROCEDURE FOR PREPARING IMPACT STYRENE POLYMERISAT.
SE421612B (en) PROCEDURE FOR PREPARING ALFA-6-DEOXI-5-HYDROXYTETRACYCLINE
DK223175A (en) PROCEDURE FOR PREPARING PYRIDOBENZODIAZEPINONS
SE418292B (en) PROCEDURE FOR PREPARING 5-ARYL-2-FURAMIDINES
SE400960B (en) PROCEDURE FOR PREPARING ALHŸ3 (POŸ4) Ÿ2 3HŸ2O
SE414926B (en) PROCEDURE FOR PREPARING 1-ALKYL-2- (PHENOXIMETHYL) -5-NITROIMIDAZOLES
SE422057B (en) PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED OMEGA-NOR-13,14-DEHYDRO-PROSTAGLANDINES
SE422210B (en) ANALOGY PROCEDURE FOR PREPARING SUBSTITUTED INDOLS
DK154890C (en) PROCEDURE FOR PREPARING 7BETA-ACYLAMINO-7ALFA-ALCOXYCEPHALOSPORINES
SE7504413L (en) PROCEDURE FOR PREPARING A NEW ANTIBIOTIC SUBSTANCE.
SE7508936L (en) PROCEDURE FOR MAKING A CINNAMAMID.
SE421310B (en) PROCEDURE FOR PREPARING SUBSTITUTED BENZOYLPYRIDINES
IT1040067B (en) PROCEDURE FOR PREPARING CHLOROSILANS
DK505275A (en) PROCEDURE FOR PREPARING 7,7-DIPHENYLHEXAHYDRO-1,4-OXAZEPINES

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500501-7

Effective date: 19940810

Format of ref document f/p: F